Skip to main content

Peer Review reports

From: Investigating the effects of Pirfenidone on TGF-β1 stimulated non-SMAD signaling pathways in Dupuytren’s disease -derived fibroblasts

Original Submission
5 Sep 2018 Submitted Original manuscript
5 Oct 2018 Author responded Author comments - Chaoming Zhou
Resubmission - Version 2
5 Oct 2018 Submitted Manuscript version 2
23 Oct 2018 Reviewed Reviewer Report - David O'Gorman
16 Nov 2018 Reviewed Reviewer Report - Ruud A. Bank
14 Dec 2018 Author responded Author comments - Chaoming Zhou
Resubmission - Version 3
14 Dec 2018 Submitted Manuscript version 3
17 Dec 2018 Reviewed Reviewer Report - David O'Gorman
8 Jan 2019 Reviewed Reviewer Report - Ruud A. Bank
8 Feb 2019 Author responded Author comments - Chaoming Zhou
Resubmission - Version 4
8 Feb 2019 Submitted Manuscript version 4
27 Feb 2019 Author responded Author comments - Chaoming Zhou
Resubmission - Version 5
27 Feb 2019 Submitted Manuscript version 5
Publishing
3 Mar 2019 Editorially accepted
30 Mar 2019 Article published 10.1186/s12891-019-2486-3

You can find further information about peer review here.

Back to article page